The Glaucoma 360 Annual Gala showcases the visionaries and catalysts who share Glaucoma Research Foundation's mission to prevent vision loss from glaucoma.
The Annual Gala includes presentation of The Catalyst Award (Glaucoma Research Foundation's highest honor), the President's Reception and silent auction, the gala dinner, a lively live auction, and a special private performance. This year's performance was by Tony Lindsay, an award-winning performer best known for singing with the group Santana).
The Glaucoma 360 Annual Gala took place on February 8, 2018 at the Palace Hotel in San Francisco.
L-R: Jeffrey L. Goldberg, MD, PhD, George A. Cioffi, MD, Joel S. Schuman, MD, FACS
L-R: Cheryl Rowe-Rendleman, PhD with Libby and Eugene de Juan, Jr., MD
L-R: Rick Halprin, CPA, Robert Fechtner, MD, Lisa and Martin Wax, MD
Volunteers from Delta Gamma assisted with the auction to raise funds for glaucoma research and education.
L-R: Chris Calcaterra, Thomas W. Burns (2018 Catalyst Award recipient), Bob More, and William Link, PhD
Nobuko Saito Cleary and Gary Cleary, PharmD, PhD with their friends and special guests
Cynthia Mattox, MD, FACS enjoying the gala dinner with Mark Mannis, MD
James D. Brandt, MD and friends take part in the live auction to raise funds for glaucoma research.
Thomas M. Brunner presents the 2018 President's Award to Carl V. Migliazzo, MD
L-R: Amanda Eddy, Malvina Eydelman, MD, and Thomas Brunner
Adrienne Graves, PhD (right) presented the 2018 Catalyst Award to Thomas W. Burns, President and CEO of Glaukos.
L-R: Prof. Gerold Grodsky, Jonathan Hertz, Jeffrey Goldberg, MD, PhD, Edwin Shonfeld, MD; Seated: Marcia Shonfeld and Roberta Sherman
Bruce Essman with Carla J. Siegfried, MD (awarded the 2018 Shaffer Prize at the gala)
Tony Lindsay performed at the gala with his all-star band.
Save the date for next year's Glaucoma 360 Annual Gala — January 31, 2019.
There is great interest among glaucoma patients, scientists and doctors alike, in discovering regenerative therapies for the optic nerve and translating them from the laboratory to the clinic — and stem cell therapy is one of several promising approaches being studied.